According to the current clinical practice guidelines for chronic obstructive pulmonary
disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β 2 agonist …

Current guidelines for the management of chronic obstructive pulmonary disease (COPD)
recommend limiting the use of inhaled corticosteroids (ICS) to patients with more severe …

The effectiveness of inhaled corticosteroids (ICS) in patients with chronic obstructive
pulmonary disease (COPD) remains controversial. Randomized controlled trials, meta …

International guidance on chronic obstructive pulmonary disease (COPD) management
recommends the use of inhaled corticosteroids (ICS) in those patients at increased …

Importance of the field: Chronic obstructive pulmonary disease (COPD) is a disease
characterized by chronic airflow obstruction and a progressive lung function decline …

Current guidelines limit regular use of inhaled corticosteroids (ICS) to a specific subgroup of
patients with chronic obstructive pulmonary disease (COPD) in whom the forced expiratory …

The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …

Chronic obstructive pulmonary disease (COPD) guidelines suggest using inhaled
corticosteroids (ICS) in patients with severe airflow limitation or those at high risk of …

Introduction: The frequent use of inhaled corticosteroids (ICSs), especially at higher doses,
has been accompanied by concern about both systemic and local side effects. Patients …

Inhaled corticosteroids in chronic obstructive pulmonary dis... : Current Opinion in Pulmonary
Medicine Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a long-term …